Browser-side verification
Verify Methylprednisolone
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "methylprednisolone",
"nameEn": "Methylprednisolone",
"nameTh": "เมทิลเพรดนิโซโลน",
"class": "Corticosteroid — intermediate-acting glucocorticoid",
"mechanism": "glucocorticoid สังเคราะห์ออกฤทธิ์ปานกลาง ความแรงสูงกว่า prednisolone เล็กน้อย มีฤทธิ์ mineralocorticoid ต่ำกว่า; รูปแบบ Depo-Medrol เป็น depot ออกฤทธิ์ยาว",
"brandNamesTh": [
"Medrol",
"Depo-Medrol",
"Solu-Medrol"
],
"indications": [
{
"text": "ภาวะอักเสบและภูมิแพ้; รูปแบบ depot (Depo-Medrol) ใช้ในแมวเมื่อให้ยากินยาก; Solu-Medrol IV สำหรับภาวะเฉียบพลัน",
"cites": [
"merck-glucocorticoid"
]
}
],
"contraindications": [
{
"text": "รูปแบบ depot ถอนกลับไม่ได้หากเกิดผลข้างเคียง; ข้อห้ามเหมือน glucocorticoid อื่น (เบาหวาน, ติดเชื้อ, NSAID ร่วม, แผล GI)",
"cites": [
"merck-glucocorticoid"
]
}
],
"sideEffects": [
{
"text": "PU/PD, polyphagia, ภูมิคุ้มกันลด, iatrogenic Cushing; depot form ออกฤทธิ์ยาวควบคุมยาก",
"cites": [
"merck-glucocorticoid"
]
}
],
"dosages": [
{
"species": "canine",
"indication": "Anti-inflammatory",
"route": "PO",
"dose": "0.5–1 mg/kg/วัน (anti-inflammatory; ใกล้เคียง prednisolone)",
"notes": "Depo-Medrol depot: ยืนยันขนาด/ช่วงห่างกับ faculty",
"cites": [
"merck-glucocorticoid"
]
}
],
"citations": [
{
"id": "merck-glucocorticoid",
"type": "textbook",
"title": "Glucocorticoids / Anti-inflammatory Agents — MSD/Merck Veterinary Manual",
"year": 2025,
"url": "https://www.merckvetmanual.com/pharmacology/anti-inflammatory-agents/corticosteroids",
"note": "Merck corticosteroid pharmacology — anti-inflammatory vs immunosuppressive dosing + relative potency. Copyrighted, cited not mirrored.",
"cid": null
},
{
"id": "dailymed-methylprednisolone",
"type": "regulatory-database",
"title": "Methylprednisolone — NLM DailyMed (FDA Structured Product Labeling)",
"year": 2025,
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=methylprednisolone",
"note": "Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.",
"cid": "8e564b17eab789f9c6eac0e7e1bea7b8ba22b76353cc61306848bf530237e6e7"
},
{
"id": "atc-H02AB04",
"type": "guideline",
"title": "ATC H02AB04 — Methylprednisolone",
"year": 2025,
"url": "https://www.whocc.no/atc_ddd_index/?code=H02AB04&showdescription=no",
"note": "Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.",
"cid": "5b6c2aeb7ec659ba43b335378d861104928ed48cd1d72dcc0d905b7bb0a3099b"
},
{
"id": "pubchem-methylprednisolone",
"type": "monograph",
"title": "Methylprednisolone — PubChem search",
"year": 2025,
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Methylprednisolone",
"note": "Cross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.",
"cid": "3cf15f5c7b8cf2ef1350268d1617d82cb6a879da04b07090d518b8865565b0bf"
}
],
"mirroredFrom": [
{
"id": "dailymed",
"name": "NLM DailyMed",
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=methylprednisolone",
"asOfDate": "2026-05-27",
"license": "U.S. Government work — public domain. Attribution recommended."
},
{
"id": "atc",
"name": "WHO ATC Classification",
"url": "https://www.whocc.no/atc_ddd_index/?code=H02AB04&showdescription=no",
"asOfDate": "2026-05-27",
"license": "WHO publication, free for use with attribution"
},
{
"id": "pubchem",
"name": "PubChem (NIH/NLM)",
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Methylprednisolone",
"asOfDate": "2026-05-27",
"license": "NIH/NLM public domain"
}
],
"mirrorCIDs": [
{
"sourceId": "dailymed",
"cid": "8e564b17eab789f9c6eac0e7e1bea7b8ba22b76353cc61306848bf530237e6e7",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "atc",
"cid": "5b6c2aeb7ec659ba43b335378d861104928ed48cd1d72dcc0d905b7bb0a3099b",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "pubchem",
"cid": "3cf15f5c7b8cf2ef1350268d1617d82cb6a879da04b07090d518b8865565b0bf",
"capturedAt": "2026-05-27",
"status": "stub"
}
],
"codes": {
"atc": {
"code": "H02AB04",
"name": "Methylprednisolone",
"level": 5
},
"rxnorm": {
"cui": "6902",
"name": "Methylprednisolone"
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-05-27",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-05-27",
"version": 1,
"changelog": [
{
"version": 0,
"date": "2026-05-27",
"summary": "Seed entry — cross-checked from 3 authoritative sources (NLM DailyMed, WHO ATC Classification, PubChem (NIH/NLM)). ATC H02AB04 + RxNorm 6902. Thai translation + faculty review pending."
},
{
"version": 1,
"date": "2026-05-27",
"summary": "Clinical content compiled from cited sources — methylprednisolone intermediate-acting profile + depot caution verified against Merck corticosteroids. Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
]
}Public keys used
[]